Institut NeuroMyoGene-PGNM UCBL-CNRS UMR5261 INSERM U1315, Lyon, France.
Institut NeuroMyoGene-PGNM UCBL-CNRS UMR5261 INSERM U1315, Lyon, France.
Biochim Biophys Acta Mol Cell Res. 2024 Oct;1871(7):119809. doi: 10.1016/j.bbamcr.2024.119809. Epub 2024 Aug 11.
Friedreich's ataxia (FA) is one of the most frequent inherited recessive ataxias characterized by a progressive sensory and spinocerebellar ataxia. The main causative mutation is a GAA repeat expansion in the first intron of the frataxin (FXN) gene which leads to a transcriptional silencing of the gene resulting in a deficit in FXN protein. The nature of the mutation (an unstable GAA expansion), as well as the multi-systemic nature of the disease (with neural and non-neural sites affected) make the generation of models for Friedreich's ataxia quite challenging. Over the years, several cellular and animal models for FA have been developed. These models are all complementary and possess their own strengths to investigate different aspects of the disease, such as the epigenetics of the locus or the pathophysiology of the disease, as well as being used to developed novel therapeutic approaches. This review will explore the recent advancements in the different mammalian models developed for FA.
弗里德里希共济失调(FA)是最常见的遗传性隐性共济失调之一,其特征是进行性感觉和脊髓小脑共济失调。主要的致病突变是在 FXN 基因的第一个内含子中的 GAA 重复扩增,导致基因的转录沉默,从而导致 FXN 蛋白的缺乏。突变的性质(不稳定的 GAA 扩增)以及疾病的多系统性质(受影响的神经和非神经部位)使得生成弗里德里希共济失调的模型极具挑战性。多年来,已经开发出几种用于 FA 的细胞和动物模型。这些模型都是互补的,各自具有优势,可以研究疾病的不同方面,例如基因座的表观遗传学或疾病的病理生理学,以及用于开发新的治疗方法。本综述将探讨为 FA 开发的不同哺乳动物模型的最新进展。